Updated: 12/15/2019

Benign Prostatic Hyperplasia (BPH)

0%
Topic
Review Topic
0
0
N/A
N/A
Questions
3
0
0
0%
0%
Evidence
4
0
0
Topic
Overview
 

 
Snapshot
  • A 70-year-old man presents to his physician with difficulty initiating a stream and post-void dribbling. He also reports having increased urinary urgency and a weak urinary stream. Medical history is significant for hypertension and is not on medication. On digital rectal exam, his prostate is enlarged, non-tender, firm, and smooth. Urinalysis is unremarkable and prostate-specific antigen is elevated. He is started on tamsulosin to improve his lower urinary tract symptoms.
Introduction
  • Clinical definition
    • benign hyperplasia of the stromal and epithelial cells of the prostate that results in lower urinary tract symptoms (LUTS) such as
      • post-void dribbling
      • increased urinary frequency and urgency
      • nocturia
      • weak urinary stream
  • Epidemiology
    • demographics
      • men > 45 years of age
  • Pathogenesis
    • unclear; however, chronic inflammation and hormonal and vascular mechanisms may play a role
  • Associated conditions
    • obesity and metabolic syndromes
    • hypertension
    • type 2 diabetes mellitus
  • Prognosis
    • symptoms slowly and progressively worsen
Presentation
  • Symptoms
    • issues with urinary storage
      • e.g., nocturia, increased urinary frequency, urinary incontinence, and urgency
    • issues with voiding
      • e.g., weak urinary stream, hesistancy, straining to void, and post-void dribbling 
      • exacerbated by alpha-1 agonists 
    • irritative issues
      • e.g., urgency and increased urinary frequency 
  • Physical exam
    • digital rectal exam
      • a non-tender, smooth, elastic, and firm enlarged prostate
Studies
  • Labs
    • urinalysis
      • to detect the presence of a urinary tract infection or blood
    • prostate-specific antigen
      • non-specific
  • Diagnostic criteria
    • this is a clinical diagnosis based on history (e.g., storage, voiding, and/or irritating urinary symptoms) and physical exam (e.g., a non-tender, smooth, elastic, and firm enlarged prostate)
Differential
  • Prostate cancer
  • Prostatitis
  • Urinary tract infection
  • Bladder cancer
Treatment
  • Medical
    • α1-blockers (e.g., terazosin and tamsulosin)
      • indication
        • considered initial therapy in patients with LUTS secondary to BPH
          • results in immediate relief
          • caution in patients on a phosphodiesterase-5 inhibitor as this can cause severe hypotension
    • 5-α reductase inhibitors (e.g., finasteride)  
      • indication
        • can be used as alternative treatment in patients with LUTS secondary to BPH who cannot tolerate α1-blockers
          • takes time (6-12 months) for symptom improvement to be appreciated
    • phosphodiesterase-5 inhibitors (e.g., sildenafil)
      • indication
        • a reasonable treatment option in patients with LUTS secondary to BPH who have erectile dysfunction
  • Surgical
    • transurethral resection of the prostate
      • indication
        • a treatment option in patients who are unresponsive to medical treatment
        • in patients with recurrent UTIs, bladder stones, or gross hematuria secondary to their BPH
      • complication
        • retrograde ejaculation
        • erectile dysfunction
          • this is uncommon
Complications
  • UTI
  • Nephrolithiasis
  • Bladder stones
  • Chronic kidney disease
  • Hydronephrosis

 

Please rate topic.

Average 4.7 of 3 Ratings

Questions (3)
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK

(M2.RL.17.4684) A 73-year-old man presents to his primary care physician complaining of increased urinary frequency, nocturia, and incomplete emptying after void. He is otherwise healthy, with no active medical problems. On examination, a large, symmetric, firm, smooth prostate is palpated, but otherwise the exam is normal. Which of the following is a potential complication of the patient's present condition? Tested Concept

QID: 107344
1

Prostate cancer

8%

(1/13)

2

Hydronephrosis

77%

(10/13)

3

Bladder cancer

0%

(0/13)

4

Prostatitis

15%

(2/13)

5

Renal cancer

0%

(0/13)

M 8 D

Select Answer to see Preferred Response

Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Evidence (4)
EXPERT COMMENTS (8)
Private Note